Australia - englanti - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Yhdysvallat - englanti - NLM (National Library of Medicine)

catalent belgium sa - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated) (unii: v8pc20ubcn) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (propiolactone inactivated) - unii:wlsrj8jc6s) - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated) 15 ug in 0.5 ml

Yhdysvallat - englanti - NLM (National Library of Medicine)

catalent belgium sa - influenza a virus a/victoria/361/2011 ivr-165 (h3n2) antigen (propiolactone inactivated) (unii: 3872llc68g) (influenza a virus a/victoria/361/2011 ivr-165 (h3n2) antigen (propiolactone inactivated) - unii:3872llc68g), influenza b virus b/hubei-wujiagang/158/2009 bx-39 antigen (propiolactone inactivated) (unii: 3s1zbq2b9i) (influenza b virus b/hubei-wujiagang/158/2009 bx-39 antigen (propiolactone inactivated) - unii:3s1zbq2b9i), influenza a virus a/christchurch/16/2010 nib-74 (h1n1) antigen (propiolactone -

Malta - englanti - Medicines Authority

accord healthcare limited - fluorouracil - solution for infusion or injection - fluorouracil 50 mg/ml - antineoplastic agents

Etelä-Afrikka - englanti - South African Health Products Regulatory Authority (SAHPRA)

cipla -

Kanada - englanti - Health Canada

teva canada limited - deferasirox - tablet for suspension - 125mg - deferasirox 125mg - heavy metal antagonists